AAAAAA
Results: 1-25/39
Authors:
FRICK J
JUNGWIRTH A
ROVAN E
KALLA N
Citation: J. Frick et al., THE PILL FOR MEN - UPDATE ON FERTILITY-CO NTROL IN MEN, Gynakologisch-geburtshilfliche Rundschau, 38(1), 1998, pp. 50-53
Authors:
JUNGWIRTH A
GOMAHR A
JOOS H
FRICK J
MOOYOUNG AJ
NASH H
SCHLEGEL PN
KUZMA P
BARDIN CW
Citation: A. Jungwirth et al., POTENT LHRH-AGONIST FOR TESTOSTERONE DEPRIVATION (NEW MODE OF APPLICATION), The Journal of urology, 159(5), 1998, pp. 494-494
Authors:
JUNGWIRTH A
FRICK J
SCHALLY AV
HALMOS G
GROOT K
SZEPESHAZI K
PINSKI J
Citation: A. Jungwirth et al., SOMATOSTATIN ANALOG RC-160, LH-RH ANTAGONIST CETRORELIX AND BOMBESIN ANTAGONIST RC-3940-II INHIBIT GROWTH OF CAKI-1 HUMAN RENAL-CARCINOMA, The Journal of urology, 159(5), 1998, pp. 727-727
Authors:
FRICK J
PRECETTI C
MITCHELL CA
Citation: J. Frick et al., PREDICTING LETTUCE CANOPY PHOTOSYNTHESIS WITH STATISTICAL AND NEURAL-NETWORK MODELS, Journal of the American Society for Horticultural Science, 123(6), 1998, pp. 1076-1080
Authors:
MACK D
HACKER GW
HAUSERKRONBERGER C
FRICK J
DIETZE O
Citation: D. Mack et al., VASOACTIVE INTESTINAL POLYPEPTIDE (VIP) AND NEUROPEPTIDE TYROSINE (NPY) IN PROSTATE CARCINOMA, European journal of cancer, 33(2), 1997, pp. 317-318
Authors:
JONAS U
HOFNER K
MADERSBACHER H
HOLMDAHL TH
BUCHER A
FRICK J
HEIDLER H
PFLUGER H
PRIMUS G
SCHMIDBAUER C
ZECHNER O
ALLOUSSI S
ANTHUBER C
BLAU U
DIMPFL T
FLACH K
FROHLICH G
FROHNEBERG D
GEIER G
HANNAPPEL J
HARTUNG R
HAUBENSAK K
HERRLINGER A
HILLER O
HOFSTETTER A
HORSCH R
JUNEMANN KP
KINDT J
KOSZEGI F
LAHM AW
LAMMLE G
LAVAL KU
MELCHIOR H
METHFESSEL HD
RUDOLPH R
TERHORST B
VILMAR W
WEIDENFELD M
FRYKMAN H
GRANBERG G
HAENDLER L
LARSSON C
WINBERG T
Citation: U. Jonas et al., EFFICACY AND SAFETY OF 2 DOSES OF TOLTERODINE VERSUS PLACEBO IN PATIENTS WITH DETRUSOR OVERACTIVITY AND SYMPTOMS OF FREQUENCY, URGE INCONTINENCE, AND URGENCY - URODYNAMIC EVALUATION (VOL 15, PG 144, 1997), World journal of urology, 15(3), 1997, pp. 210-210
Authors:
JONAS U
HOFNER K
MADERSBACHER H
HOLMDAHL TH
BUCHER A
FRICK J
HEIDLER H
PFLUGER H
PRIMUS G
SCHMIDBAUER C
ZECHNER O
ALLOUSSI S
ANTHUBER C
BLAU U
DIMPFL T
FLACH K
FROHLICH G
FROHNEBERG D
GEIER G
HANNAPPEL J
HARTUNG R
HAUBENSAK K
HERRLINGER A
HILLER O
HOFSTETTER A
HORSCH R
JUNEMANN KP
KINDT J
KOSZEGI F
LAHM AW
LAMMLE G
LAVAL KU
MELCHIOR H
METHFESSEL HD
RUDOLPH R
TERHORST B
VILMAR W
WEIDENFELD M
FRYKMAN H
GRANBERG G
HAENDLER L
LARSSON C
Citation: U. Jonas et al., EFFICACY AND SAFETY OF 2 DOSES OF TOLTERODINE VERSUS PLACEBO IN PATIENTS WITH DETRUSOR OVERACTIVITY AND SYMPTOMS OF FREQUENCY, URGE INCONTINENCE, AND URGENCY - URODYNAMIC EVALUATION, World journal of urology, 15(2), 1997, pp. 144-151
Authors:
MACK D
JUNGWIRTH A
ADAM U
KUNIT G
MILLER K
DIETZE O
FRICK J
Citation: D. Mack et al., LONG-TERM FOLLOW-UP AFTER OPEN PERINEAL CRYOTHERAPY IN PATIENTS WITH LOCALLY CONFINED PROSTATE-CANCER, European urology, 32(2), 1997, pp. 129-132
Authors:
FUERST J
FIEBIGER E
JUNGWIRTH A
MACK D
TALWAR PG
FRICK J
ROVAN E
Citation: J. Fuerst et al., EFFECT OF ACTIVE IMMUNIZATION AGAINST LUTEINIZING-HORMONE-RELEASING HORMONE ON THE ANDROGEN-SENSITIVE DUNNING R3327-PAP AND ANDROGEN-INDEPENDENT DUNNING R3327-AT2.1 PROSTATE-CANCER SUBLINES, The Prostate, 32(2), 1997, pp. 77-84
Authors:
JOOS H
SEDLMAYER F
GOMAHR A
RAHIM HBK
FRICK J
KOGELNIK HD
RETTENBACHER L
Citation: H. Joos et al., ENDOCRINE PROFILES AFTER RADIOTHERAPY IN STAGE-I SEMINOMA - IMPACT OF2 DIFFERENT RADIATION TREATMENT MODALITIES, Radiotherapy and oncology, 43(2), 1997, pp. 159-162
Authors:
KALLA NR
KAUR S
UJWAL N
MEHTA U
JOOS H
FRICK J
Citation: Nr. Kalla et al., ALPHA-GLUCOSIDASE ACTIVITY IN THE RAT EPIDIDYMIS UNDER DIFFERENT PHYSIOLOGICAL CONDITIONS, International journal of andrology, 20(2), 1997, pp. 92-95
Authors:
BUCHEL F
FRICK J
VOGES W
Citation: F. Buchel et al., SOCIAL ASSISTANCE RECIPIENCY AMONG IMMIGR ANTS IN WEST-GERMANY, Kolner Zeitschrift fur Soziologie und Sozialpsychologie, 49(2), 1997, pp. 272
Authors:
RAMON J
LYNCH TH
EARDLEY I
EKMAN P
FRICK J
JUNGWIRTH A
PILLAI M
WIKLUND P
GOLDWASSER B
FITZPATRICK JM
Citation: J. Ramon et al., TRANSURETHRAL NEEDLE ABLATION OF THE PROSTATE FOR THE TREATMENT OF BENIGN PROSTATIC HYPERPLASIA - A COLLABORATIVE MULTICENTER STUDY, British Journal of Urology, 80(1), 1997, pp. 128-134
Authors:
JUNGWIRTH A
WEIGER T
SINGH SK
PAULMICHL M
FRICK J
Citation: A. Jungwirth et al., FOLLICLE-STIMULATING-HORMONE ACTIVATES A CAMP-DEPENDENT CHLORIDE CONDUCTANCE IN TM4 SERTOLI CELLS, Biochemical and biophysical research communications, 233(1), 1997, pp. 203-206
Authors:
GSCHWENTNER M
SUSANNA A
SCHMARDA A
LAICH A
NAGL UO
ELLEMUNTER H
DEETJEN P
FRICK J
PAULMICHL M
Citation: M. Gschwentner et al., I-CLN - A CHLORIDE CHANNEL PARAMOUNT FOR CELL-VOLUME REGULATION, Journal of allergy and clinical immunology, 98(5), 1996, pp. 98-101
Authors:
NARAYAN P
TRACHTENBERG J
LEPOR H
DEBRUYNE FMJ
TEWARI A
STONE N
DAS S
JIMENEZCRUZ JF
SHEARER R
KLINGBERT I
SCHELLHAMMER PF
COSTELLO AJ
ODONOGHUE N
CRAWFORD D
COLLSTE L",SCHULTZESEEMANN,"KIRKEMO A
BADELAMANT R
WENDEROTH UK
BRAWER M
BOUFFIOUX C
MCLEOD DG
FLANIGAN RC
GONICK P
BREUL J
SCHICK E
KREIGMAIR M",KRAMER,"FRICK J",KAULEN,"BAUER H
JASKE G
HENEY N
Citation: P. Narayan et al., A DOSE-RESPONSE STUDY OF THE EFFECT OF FLUTAMIDE ON BENIGN PROSTATIC HYPERPLASIA - RESULTS OF A MULTICENTER STUDY, Urology, 47(4), 1996, pp. 497-504
Authors:
WOLL E
GSCHWENTNER M
FURST J
HOFER S
BUEMBERGER G
JUNGWIRTH A
FRICK J
DEETJEN P
PAULMICHL M
Citation: E. Woll et al., FLUORESCENCE-OPTICAL MEASUREMENTS OF CHLORIDE MOVEMENTS IN CELLS USING THE MEMBRANE-PERMEABLE DYE DIH-MEQ, Pflugers Archiv, 432(3), 1996, pp. 486-493
Authors:
ARRER E
JUNGWIRTH A
MACK D
FRICK J
PATSCH W
Citation: E. Arrer et al., TREATMENT OF PROSTATE-CANCER WITH GONADOTROPIN-RELEASING-HORMONE ANALOG - EFFECT ON LIPOPROTEIN[A], The Journal of clinical endocrinology and metabolism, 81(7), 1996, pp. 2508-2511
Authors:
MACK D
FRICK J
Citation: D. Mack et J. Frick, QUALITY-OF-LIFE IN PATIENTS UNDERGOING BACILLE CALMETTE-GUERIN THERAPY FOR SUPERFICIAL BLADDER-CANCER, British Journal of Urology, 78(3), 1996, pp. 369-371
Authors:
GSCHWENTNER M
JUNGWIRTH A
HOFER S
WOLL E
RITTER M
SUSANNA A
SCHMARDA A
REIBNEGGER G
PINGGERA GM
LEITINGER M
FRICK J
DEETJEN P
PAULMICHL M
Citation: M. Gschwentner et al., BLOCKADE OF SWELLING-INDUCED CHLORIDE CHANNELS BY PHENOL DERIVATIVES, British Journal of Pharmacology, 118(1), 1996, pp. 41-48
Authors:
GSCHWENTNER M
SUSANNA A
HOFER S
JUNGWIRTH A
FRICK J
PAULMICHL M
Citation: M. Gschwentner et al., THE PHENOL DERIVATIVES GOSSYPOL AND NDGA BLOCK CHLORIDE CHANNELS ACTIVATED AFTER CELL SWELLLNG, Biophysical journal, 70(2), 1996, pp. 213-213
Authors:
MACK D
GOMAHR A
HEROLD M
FRICK J
Citation: D. Mack et al., NEOPTERIN AS A MONITORING PARAMETER FOR TREATMENT WITH BCG IN SUPERFICIAL BLADDER-CANCER, European journal of cancer, 31A(6), 1995, pp. 1025-1026
Authors:
JUNGWIRTH A
MACK D
FRICK J
Citation: A. Jungwirth et al., D2 PROSTATE-CANCER - HALF DOSAGE OF THE LHRH-AGONISTS IS SUFFICIENT FOR COMPLETE ANDROGEN DEPRIVATION, European journal of cancer, 31A(1), 1995, pp. 128-129
Authors:
PAULMICHL M
GSCHWENTNER M
SUSANNA A
WOLL E
RITTER M
PINGGERA GM
LEITINGER M
JUNGWIRTH A
FRICK J
REIBNEGGER G
DEETJEN P
Citation: M. Paulmichl et al., PHENOL DERIVATIVES BLOCK SWELLING-INDUCED ACTIVATION OF CHLORIDE CHANNELS, The FASEB journal, 9(3), 1995, pp. 302-302
Authors:
MACK D
FRICK J
Citation: D. Mack et J. Frick, 5-YEAR RESULTS OF A PHASE-II STUDY WITH LOW-DOSE BACILLE CALMETTE-GUERIN THERAPY IN HIGH-RISK SUPERFICIAL BLADDER-CANCER, Urology, 45(6), 1995, pp. 958-961